Formaldehyde → HCID 66980534, Verbindung

HRID 1038801

Reaktionsgleichung

Reaktionsgleichung von HRID 1038801
[C:1]([CH:3]1[CH2:8][CH2:7][N:6]([C:9]([O:11][CH2:12][C:13]2[CH:18]=[CH:17][CH:16]=[CH:15][CH:14]=2)=[O:10])[CH2:5][CH2:4]1)#[N:2].[Li+].C[Si]([N-][Si](C)(C)C)(C)C.[CH2:29]=[O:30]>C1COCC1>[C:1]([C:3]1([CH2:29][OH:30])[CH2:8][CH2:7][N:6]([C:9]([O:11][CH2:12][C:13]2[CH:14]=[CH:15][CH:16]=[CH:17][CH:18]=2)=[O:10])[CH2:5][CH2:4]1)#[N:2]

Komponenten

5

Versuchsvorschrift

To a mixture of benzyl 4-cyanopiperidine-1-carboxylate (1.0 g, 4.0 mmol, Oakwood) in THF (50 mL) at about −78° C. was added LiHMDS (1.0 M solution in THF, 6.14 mL, 6.14 mmol) dropwise via syringe. The mixture was stirred for about 1 h. Paraformaldehyde (0.25 g, 8.2 mmol) was added in one portion and the mixture was stirred overnight at rt. The mixture was concentrated in vacuo and the residue was purified by preparative TLC (1:1 EtOAc/pet ether) to give benzyl 4-cyano-4-(hydroxymethyl)piperidine-1-carboxylate (0.45 g, 35%): LC/MS (Table 2, Method k) Rt=0.60 min; MS m/z: 274 (M+H)+.

Aufarbeitung

  1. stirringthe mixture was stirred overnight at rt
  2. concentrationThe mixture was concentrated in vacuo
  3. customthe residue was purified by preparative TLC (1:1 EtOAc/pet ether)

Quellen und Nachweise

ORD-Eintrag
ord-5c54e5ae32254843bbadc584dacfc6c3
Quelldatensatz
uspto-grants-2013_10
Patentnummer
US08551981B2

Verknüpfte Notizen

Wird geladen…